GO
Loading...

Pfizer Inc

More

  • Lilly psoriasis drug fares well in late-stage test Thursday, 21 Aug 2014 | 8:55 AM ET

    INDIANAPOLIS— Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

  • Final Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 12 or. 2 percent, to $75.25. Bristol-Myers Squibb Co. fell$. 26 or. 5 percent, to $50.04. Hospira rose$. 99 or 1.8 percent, to $54.91.

  • Midday Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 1:49 PM ET

    Baxter International Inc. rose$. 11 or. 1 percent, to $75.24. Bristol-Myers Squibb Co. fell$. 18 or. 4 percent, to $50.12. Hospira rose$. 70 or 1.3 percent, to $54.62.

  • Most active New York Stock Exchange-traded stocks Wednesday, 20 Aug 2014 | 1:49 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. American Eagle Outfitters Inc. rose 12.0 percent to $12.98 with 27,989,700 shares traded. Bank of America Corp. rose. 5 percent to $15.52 with 57,060,700 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 12:21 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $74.78. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $50.14. Hospira rose$. 45 or. 8 percent, to $54.37.

  • UPDATE 1-U.S. clears AstraZeneca over heart drug trial Tuesday, 19 Aug 2014 | 3:24 AM ET

    LONDON, Aug 19- The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects.

  • U.S. clears AstraZeneca over heart drug trial Tuesday, 19 Aug 2014 | 2:31 AM ET

    LONDON, Aug 19- AstraZeneca said on Tuesday the U.S. government was closing a probe into a major clinical trial used to win marketing approval for its new heart drug Brilinta and no further action was planned.

  • Investors lose out when companies flee US tax Monday, 18 Aug 2014 | 4:14 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Establishing a tax domicile abroad to avoid taxes is popular, but many US companies have failed to produce strong returns for investors.

  • LOS ANGELES, Aug 17- Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies.

  • NORWICH, England, Aug 17- Pampering leafcutter ants with fragrant rose petals and fresh oranges may seem an unlikely way to rescue modern medicine, but scientists at a lab in eastern England think it's well worth trying.

  • LONDON, Aug 15- U.S. investors are withdrawing billions of dollars from European stocks as signs of a stalled economic recovery, compounded by the Ukraine crisis, halt the past year's scramble to buy back into the region.

  • Traders work on the floor of the New York Stock Exchange (NYSE).

    U.S.stocks closed higher on Thursday at August highs despite subpar economic data around the world, and after conciliatory remarks from Putin.

  • NEW YORK, Aug 14- A federal judge rejected billionaire investor Steven A. Cohen's bid to dismiss lawsuits by Elan Corp and Wyeth shareholders who claimed they lost money because his firm SAC Capital Advisors LP conducted insider trading in the drugmakers' stocks.

  • NEW YORK, Aug 13- Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the matter said.

  • *Sanofi, MannKind aim to launch Afrezza in U.S. in Q1 2015. PARIS/ LONDON, Aug 11- French drugmaker Sanofi is betting on inhaled insulin as an alternative option to daily injections for diabetics by signing a worldwide licensing agreement with MannKind Corp worth up to $925 million.

  • BUSINESS-NEWS-SCHEDULE AT 1830 GMT / 2:30 P M ET Friday, 8 Aug 2014 | 2:38 PM ET

    Pfizer confronts surge of lawsuits over Lipitor. Pharmaceutical giant Pfizer is facing a mounting number of lawsuits by women who say the company knew its blockbuster anti-cholesterol drug Lipitor was linked to a small increased risk of type-2 diabetes but never properly warned the public.

  • 6 Dow stocks in correction territory, 4 more close Friday, 8 Aug 2014 | 10:04 AM ET
    Traders work on the floor of the New York Stock Exchange in New York.

    These six names are all trading at least 10 percent below their 52-week highs, and a number of other Dow stocks are less than 1 percentage point away.

  • Traders on the floor of the New York Stock Exchange.

    Geopolitics are likely to dominate markets Friday, with traders sensitive to even small developments.

  • Pfizer confronts surge of lawsuits over Lipitor Friday, 8 Aug 2014 | 6:43 AM ET
    Lipitor tablets

    Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its drug Lipitor.

  • Aug 8- Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the public.